X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
hematology (118) 118
humans (107) 107
index medicus (106) 106
transplantation (105) 105
female (64) 64
oncology (61) 61
immunology (56) 56
adult (45) 45
middle aged (41) 41
male (40) 40
hematology, oncology and palliative medicine (39) 39
hematopoietic stem cells (25) 25
care and treatment (23) 23
medicine, research & experimental (22) 22
antineoplastic combined chemotherapy protocols - therapeutic use (21) 21
breast neoplasms - therapy (21) 21
transplantation, autologous (21) 21
hematopoietic stem cell transplantation (20) 20
stem cells (20) 20
health aspects (19) 19
aged (18) 18
article (18) 18
cancer (18) 18
hematopoietic stem cell transplantation - methods (17) 17
cell biology (16) 16
combined modality therapy (16) 16
research (16) 16
risk factors (15) 15
treatment outcome (15) 15
therapy (14) 14
transplantation, homologous (14) 14
bone marrow transplantation (13) 13
leukemia (13) 13
t cells (13) 13
breast neoplasms - drug therapy (12) 12
chemotherapy (12) 12
high-dose chemotherapy (12) 12
retrospective studies (12) 12
versus-host-disease (12) 12
biotechnology & applied microbiology (11) 11
bone-marrow (11) 11
cells, cultured (11) 11
patient outcomes (11) 11
adolescent (10) 10
bone-marrow-transplantation (10) 10
breast neoplasms - pathology (10) 10
cell separation - methods (10) 10
hematopoietic stem cell transplantation - adverse effects (10) 10
physiological aspects (10) 10
recurrence (10) 10
bone-marrow transplantation (9) 9
complications and side effects (9) 9
disease-free survival (9) 9
fetal blood - cytology (9) 9
prognosis (9) 9
survival analysis (9) 9
young adult (9) 9
bone marrow (8) 8
breast cancer (8) 8
cells (8) 8
clinical trials as topic (8) 8
colony-stimulating factor (8) 8
dose-response relationship, drug (8) 8
fetal blood (8) 8
hematologic neoplasms - therapy (8) 8
immunotherapy (8) 8
methods (8) 8
mice (8) 8
stem-cell transplantation (8) 8
transplantation conditioning - methods (8) 8
tumor cells, cultured (8) 8
abridged index medicus (7) 7
advanced basic science (7) 7
analysis (7) 7
animals (7) 7
antigens, cd34 (7) 7
antineoplastic agents - therapeutic use (7) 7
cisplatin - administration & dosage (7) 7
cord blood (7) 7
cyclophosphamide (7) 7
cyclophosphamide - administration & dosage (7) 7
cyclophosphamide - analogs & derivatives (7) 7
ex vivo expansion (7) 7
graft vs host disease - prevention & control (7) 7
hematopoietic stem cells - cytology (7) 7
lymphocytes (7) 7
melphalan - administration & dosage (7) 7
other (7) 7
antigens, cd34 - analysis (6) 6
bone marrow - pathology (6) 6
carmustine - administration & dosage (6) 6
cd34 (6) 6
cell & tissue engineering (6) 6
child (6) 6
cyclophosphamide - therapeutic use (6) 6
dosage and administration (6) 6
genetic aspects (6) 6
graft survival (6) 6
hematopoietic stem cells - drug effects (6) 6
hematopoietic stem cells - immunology (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Science, ISSN 0036-8075, 01/2018, Volume 359, Issue 6371, pp. 97 - 103
Journal Article
Journal Article
Journal Article
Oncogene, ISSN 0950-9232, 09/2012, Volume 31, Issue 37, pp. 4085 - 4094
The myelodysplastic syndromes (MDSs) comprise a group of disorders characterized by multistage progression from cytopenias to acute myeloid leukemia (AML).... 
leukemia | Akt | SHIP-1 | TUMOR SUPPRESSION | TYROSINE KINASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | BONE-MARROW | PTEN | CELL-SURVIVAL | CELL BIOLOGY | 5-PHOSPHATASE | TEC | GENE | HEMATOPOIESIS | ONCOLOGY | GENETICS & HEREDITY | MICE | Myelodysplastic Syndromes - metabolism | Phosphoric Monoester Hydrolases - genetics | Phosphorylation | Signal Transduction | Humans | Leukemia, Myeloid, Acute - metabolism | Inositol Polyphosphate 5-Phosphatases | Phosphoric Monoester Hydrolases - deficiency | PTEN Phosphohydrolase - metabolism | Apoptosis - genetics | MicroRNAs - metabolism | Phosphatidylinositol 3-Kinases - metabolism | Cell Line, Tumor | Myeloid Cells - metabolism | Myelodysplastic Syndromes - genetics | Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases | Phosphoric Monoester Hydrolases - metabolism | Proto-Oncogene Proteins c-akt - metabolism | Bone Marrow Cells - metabolism | Physiological aspects | MicroRNA | Research | Myelodysplastic syndromes | Risk factors | Apoptosis | Proteins | Biomarkers | Oncology | Cellular biology | Leukemia | Index Medicus | Immunohistochemistry | Circuits | Immunocytochemistry | AKT protein | Lipids | Malignancy | Myelodysplastic syndrome | Western blotting | phosphoinositides | Signal transduction | Transfection | Bone marrow | Evolution | miRNA | CD34 antigen | Myeloid cells | Cell survival | Risk groups | biomarkers | Data processing | Src protein | Polymerase chain reaction | phosphatidylinositol | Stem cells | Acute myeloid leukemia | PTEN protein | inositol 5'-phosphatase
Journal Article
Journal Article
Leukemia, ISSN 0887-6924, 04/2018, Volume 32, Issue 4, pp. 960 - 970
Ibrutinib, a covalent inhibitor of Bruton Tyrosine Kinase (BTK), is approved for treatment of patients with relapsed/refractory or treatment-naive chronic... 
ONCOLOGY | SIGNALING PATHWAY | PD-L1 EXPRESSION | THERAPEUTIC TARGET | INITIAL THERAPY | STAT3 | BTK | CHRONIC LYMPHOCYTIC-LEUKEMIA | ANTITUMOR IMMUNITY | HEMATOLOGY | CANCER | T-CELLS | B-Lymphocytes, Regulatory - metabolism | Tumor Microenvironment - drug effects | Pyrazoles - therapeutic use | Protein-Tyrosine Kinases - metabolism | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | CD4-Positive T-Lymphocytes - metabolism | Programmed Cell Death 1 Receptor - metabolism | Male | B7-H1 Antigen - metabolism | Signal Transduction - drug effects | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | CD8-Positive T-Lymphocytes - drug effects | Leukemia, Lymphocytic, Chronic, B-Cell - metabolism | CD8-Positive T-Lymphocytes - metabolism | Female | Aged | B-Lymphocytes, Regulatory - drug effects | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | CD4-Positive T-Lymphocytes - drug effects | STAT3 Transcription Factor - metabolism | Immune Tolerance - drug effects | Chronic lymphocytic leukemia | Cellular signal transduction | Genetic aspects | Research | Drug therapy | Phosphorylation | Transcription | PD-1 protein | CD8 antigen | Leukemia | Interleukin | Lymphocytes T | Lymphocytes | Peripheral blood | Inhibition | Protein-tyrosine kinase | Tyrosine | Chronic lymphatic leukemia | Immune response | Immunomodulation | Stat3 protein | Exploration | Lymphatic leukemia | Patients | Bruton's tyrosine kinase | Immunological tolerance | CD4 antigen | Signaling | Immunosuppression | Lymphocytes B | PD-L1 protein | Index Medicus
Journal Article
Leukemia, ISSN 0887-6924, 07/2013, Volume 27, Issue 7, pp. 1538 - 1547
Journal Article
Brain Behavior and Immunity, ISSN 0889-1591, 11/2017, Volume 66, pp. e25 - e25
Temozolomide in combination with cranial radiation therapy after surgery is standard of care treatment for glioblastoma. However, cognitive impairment is a... 
Stem cells | Brain damage | Chemotherapy | Memory | Cancer
Journal Article
Journal Article
Bone Marrow Transplantation, ISSN 0268-3369, 04/2017, Volume 52, Issue 4, pp. 580 - 587
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 10/2017, Volume 99, Issue 2, pp. E432 - E433
Journal Article